Sejong, South Korea

Hyung Soo Yuh

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Angiolab, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyung Soo Yuh. Retrieved from https://idiyas.com/inventor/hyung-soo-yuh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hyung Soo Yuh

Introduction: Hyung Soo Yuh is a notable inventor based in Sejong-Si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of otitis media with effusion. His innovative work has led to the development of a unique pharmaceutical composition that utilizes natural extracts.

Latest Patents: Hyung Soo Yuh holds 1 patent for his invention titled "Pharmaceutical composition comprising a fraction of leaf extract." This patent focuses on a composition designed to prevent or treat otitis media with effusion, highlighting the effectiveness of a specific fraction of leaf extract as an active ingredient.

Career Highlights: Yuh is currently associated with Angiolab, Inc., where he continues to advance his research and development efforts. His work at Angiolab has positioned him as a key player in the pharmaceutical industry, contributing to innovative solutions for common health issues.

Collaborations: Some of his notable coworkers include Min-Young Kim and Byung Young Park. Their collaborative efforts have further enhanced the research and development initiatives at Angiolab, fostering a productive environment for innovation.

Conclusion: Hyung Soo Yuh's contributions to pharmaceutical innovation demonstrate the potential of natural extracts in medical treatments. His work not only addresses important health concerns but also showcases the importance of research and collaboration in the field of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…